4.18SAR
292.40 MSAR
1.10 BSAR
21.00 M
About JAMJOOM PHARMACEUTICALS FACTORY CO.
Sector
CEO
Tarek Youssef Hosni
Headquarters
Jeddah
Website
Founded
1994
FIGI
BBG01C5P2446
Jamjoom Pharmaceuticals Factory Co. engages in the development, manufacturing, and marketing of generic pharmaceutical products. It operates through Pharmaceutical Products and Consumer Health Products segments. The Pharmaceutical Products segment represents medicines or drugs that are essential for the prevention and treatment of diseases, and protection of public health. The Consumer Health Products segment covers products that does not require the oversight of a health care practitioner. The firm's products are primarily sold in Saudi Arabia, Egypt, Iraq, Gulf countries, and North Africa countries. The company was founded by Yousuf Mohammed Salah Abdulaziz Jamjoom on September 22, 1994 and is headquartered in Jeddah, Saudi Arabia.
✅ 4015 JAMJOOM PHARMA 🔥NO LIQUDITY SWEAP NO ENTRY.
STRUCTURE IS CHANGING ANYTIME.
EVERY CANDLE HAS LIQUIDITY.
PRICE ALWAYS NEED LIQUIDITY.
Nobody Knows Where is Price Going.
Hey traders, here is the analysi.
If you guys like my analysis please hit like?? and follow.
Thanks.
SMART MONEY CONCEPT.
identify Liquidity Or Becom
Three white soldiersJamjoom Pharma Will make three white soldiers pattern ??
The three soldiers candlestick pattern is a relatively simple pattern to identify
It can be used to confirm other bullish signals
However, it is important to remember that no technical indicator is 100% accurate, so it is always import
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4015 is 130.00 SAR — it has increased by 0.46% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange JAMJOOM PHARMACEUTICALS FACTORY CO. stocks are traded under the ticker 4015.
4015 stock is 2.66% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is JAMJOOM PHARMACEUTICALS FACTORY CO. there?
JAMJOOM PHARMACEUTICALS FACTORY CO. revenue for the last quarter amounts to 293.00 M SAR despite the estimated figure of 272.00 M SAR. In the next quarter revenue is expected to reach 197.00 M SAR.
Yes, you can track JAMJOOM PHARMACEUTICALS FACTORY CO. financials in yearly and quarterly reports right on TradingView.
4015 stock has fallen by 1.52% compared to the previous week, the month change is a 7.14% fall, over the last year JAMJOOM PHARMACEUTICALS FACTORY CO. has showed a 96.97% increase.
4015 net income for the last quarter is 44.48 M SAR, while the quarter before that showed 77.25 M SAR of net income which accounts for −42.41% change. Track more JAMJOOM PHARMACEUTICALS FACTORY CO. financial stats to get the full picture.
Like other stocks, 4015 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAMJOOM PHARMACEUTICALS FACTORY CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JAMJOOM PHARMACEUTICALS FACTORY CO. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JAMJOOM PHARMACEUTICALS FACTORY CO. stock shows the buy signal. See more of JAMJOOM PHARMACEUTICALS FACTORY CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JAMJOOM PHARMACEUTICALS FACTORY CO. future price: according to them, 4015 price has a max estimate of 143.31 SAR and a min estimate of 140.00 SAR. Read a more detailed JAMJOOM PHARMACEUTICALS FACTORY CO. forecast: see what analysts think of JAMJOOM PHARMACEUTICALS FACTORY CO. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAMJOOM PHARMACEUTICALS FACTORY CO. EBITDA is 340.42 M SAR, and current EBITDA margin is 31.17%. See more stats in JAMJOOM PHARMACEUTICALS FACTORY CO. financial statements.